Osteoporosis
NOFSA 2024 Masterclass: Diagnosing osteoporosis – whom to treat
Login/Register now to access the cpd activity!
Clinical research and practice often focus heavily on cardiology, which may lead to the underdiagnosis of conditions like osteoporosis. Osteoporosis, a common metabolic bone disease, is underdiagnosed and affects one in three women and one in five men over 50. The 2024 Osteoporosis Masterclass by NOFSA explores various diagnostic methods and emphasises the importance of recognising and treating osteoporosis across all population groups in South Africa.
You will learn about:
- Available modalities for the diagnosis of osteoporosis
- Clinical risk factors for the development of osteoporosis and increasing risk for major osteoporotic fracture
- Features of each diagnostic modality that indicate the need for initiation of treatment for osteoporosis.
Dr Willem de Lange
Endocrinologist.
Dr Willem de Lange is a prominent endocrinologist with a specialisation in metabolic bone diseases. He began his academic journey at Fichardtpark Secondary School in Bloemfontein, South Africa, and earned his MB. ChB. in General Medicine from the University of the Free State in 2001. He continued his studies, obtaining an M. Med. in Internal Medicine in 2007, a Certificate in Endocrinology and Metabolism in 2010, and a Ph.D. in Metabolic Bone Disease in 2021.
Dr de Lange’s professional career includes significant roles in both clinical and academic settings. Starting as an intern at Universitas Academic Complex in 2002, he advanced to positions such as Medical Officer and Senior Consultant in Endocrinology. He also served as a Senior Lecturer and Acting Head at the University of the Free State. In 2013, he transitioned to private practice at Medi-Clinic Hospital in Bloemfontein, where he continues to practice.
He is an active member of several professional organisations, including the National Osteoporosis Foundation of South Africa (NOFSA) and the Society for Endocrinology, Metabolism, and Diabetes South Africa (SEMDSA). He has held significant roles such as Vice-Chair of SEMDSA and Director of the Metabolic Bone Research Unit at the University of the Free State.
Dr de Lange has made substantial research contributions, publishing studies on various endocrinology and bone health topics. His notable works include studies on CKMB elevation, benign paraganglioma during pregnancy, and the impact of HIV/AIDS on bone health. He is also a certified clinical densitometrist and an influential member of various advisory and organising committees.
In addition to his academic and clinical work, Dr de Lange is dedicated to community outreach. He has organised World Diabetes Day events and the University of the Free State Bone Symposium, demonstrating his commitment to public health education and advocacy.
Dr de Lange’s career reflects his dedication to advancing endocrinology, particularly metabolic bone diseases, and his continuous efforts in medical education and community health.
